University of Washington high-dose cyclophosphamide, mitoxantrone, and etoposide experience in metastatic breast cancer: unexpected cardiac toxicity.
Gralow
J R
JR
Livingston
R B
RB
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017322:Clinical Trials, Phase II as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced*; D006801:Humans; D008485:Medical Audit; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D012180:Retraction of Publication as Topic; D015871:Scientific Misconduct; D013019:South Africa; D014861:Washington
D005047:Etoposide; D003520:Cyclophosphamide; D008942:Mitoxantrone